SAN DIEGO, Oct. 19, 2011 /PRNewswire/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the
Company's Chief Executive Officer, Brian M.
Culley, will present at the 10th Annual BIOInvestor Forum
Conference on Wednesday, October 26,
2011 at 1:30 p.m. Pacific
time, in the Sea Cliff Salon at the Palace Hotel in
San Francisco.
Interested parties can access a live audio webcast and slide
presentation on the ADVENTRX Pharmaceuticals web site at
www.adventrx.com. An archived presentation will be available on the
web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company
focused on developing proprietary product candidates. The
Company's current lead product candidates are ANX-188, a novel,
purified, rheologic and antithrombotic compound initially being
developed as a first-in-class treatment for pediatric patients with
sickle cell disease in acute crisis, and ANX-514, a detergent-free
formulation of the blockbuster drug Taxotere®, which recently went
off-patent. The Company is seeking a partner or outside
investor for its Exelbine program. More information can be
found on the Company's web site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.